ValGenesis Partners with Validator K.K. to Revolutionize Validation Services in Japanese Life Sciences Sector

03 July 2024 | Wednesday | News


“Japan’s top ranking in the global pharmaceutical market is supported by tireless R&D and quality control efforts. With Japan's current shrinking population and labor shortage, productivity improvements are inevitable. Digital transformation is necessary to accelerate adaptation with sustainable growth.”
Image Source : Public Domain

Image Source : Public Domain

ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and Validator K.K., a reputed Japanese validation products and services company, have entered into a strategic reseller partnership that leverages Validator’s unique on-site validation services model for the Japanese life sciences sector.

 

Established in 2015, Validator is recognized for its commitment to quality and continuous improvement, as evidenced by its ISO9001 certification. The company’s unique business model, featuring on-site validation services, has been well-received by companies that find it challenging to secure in-house validation staff, have high travel costs, or require equipment that needs expertise and cannot be entrusted to other companies.

ValGenesis is the industry innovator of digitized validation. The company’s platform, which includes its flagship VLMS offering, is used in over 100,000 GMP systems worldwide, helping life sciences companies advance their digital transformation strategy, enforce compliance, and enable standardization with 100% digital, risk-based validation software.

Validator’s services solve a range of key issues within the pharmaceutical industry, making them a go-to partner in Japanese life sciences. As a ValGenesis reseller partner in Japan, customers can leverage Validator’s on-site services model alongside ValGenesis VLMS, the industry standard digital validation platform.

This unique service model presents exclusive benefits to Validator customers, including on-demand expertise with flexible scaling up or down based on customer needs, comprehensive risk management and risk mitigation through the team’s extensive service experience, increased budget flexibility, and more importantly, improved quality assurance.

“With Japan being the world’s second-largest pharma and medtech market and a key innovation center for the global life sciences industry, ValGenesis is honored to enter this market through a reliable partner, like Validator,” says Bo Olsen, ValGenesis’ SVP of Partners. “Through Validator’s on-site service model, customers can now access world-class smart solutions, like ValGenesis VLMS, that supports digital transformation and brings value to each step of a company’s validation and manufacturing processes. Our partnership with Validator presents the ideal approach to digitization that is adapted specifically to the country’s and industry’s conditions.”

“We eagerly look forward to this unique collaboration with ValGenesis, a leading enterprise in validation lifecycle management systems. Paper-based validation is still common in Japan, however with the recent updates regarding GMP audits, paper-based validation management is reaching its limits. We are honored to build this partnership in response to customer and government requirements through ValGenesis VLMS,” says Tamura Hiroki, Representative Director of Validator K.K., Japan. “Japan’s top ranking in the global pharmaceutical market is supported by tireless R&D and quality control efforts. With Japan's current shrinking population and labor shortage, productivity improvements are inevitable. Digital transformation is necessary to accelerate adaptation with sustainable growth.”

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close